Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one

By Hurwitz J.L.   Soike K.F.   Sangster M.Y.   Portner A.   Sealy R.E.   Dawson D.H.   Coleclough C.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 533-540

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys

By Durbin A.P.   Wyatt L.S.   Siew J.   Moss B.   Murphy B.R.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1324-1330

Elsevier

Access to resources Recommend Favorite

Evaluation of the immunocontraceptive potential of Escherichia coli expressed recombinant non-human primate zona pellucida glycoproteins in homologous animal model

By Govind C.K.   Srivastava N.   Gupta S.K.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 78-88

Elsevier

Access to resources Recommend Favorite